Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetics of Once Daily Subcutaneous Methylnaltrexone in Neurointensive Care Patients With High Dose Sufentanil Analgosedation

NCT01889290 is registered in ClinicalTrials.gov with University of Zurich as lead sponsor.

NCT NCT01889290
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01889290 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetics of Once Daily Subcutaneous Methylnaltrexone in Neurointensive Care Patients With High Dose Sufentanil Analgosedation
Lead sponsor
University of Zurich
Phase
Phase 1
Overall status
Completed
Start date
February 28, 2014
Completion date
June 30, 2016
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

opioid use, unspecified with other opioid-induced disorder